The BioWorld Insider podcast: Bracing for the impact of tariffs and grant cuts
April 23, 2025
As pharma deals with the impact of U.S. NIH grant cuts and the imposition of tariffs, a lot of pressure is shifting to smaller and midcap companies, according to two executives who spoke on the newest BioWorld Insider podcast.